Literature DB >> 752405

Activity of human prostatic acid phosphatase toward purine 5'-phosphonucleosides.

E Dziembor-Gryszkiewicz, M Fikus, Z Kazimierczuk, W Ostrowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 752405

Source DB:  PubMed          Journal:  Bull Acad Pol Sci Biol


× No keyword cloud information.
  6 in total

1.  Concentration-dependent dissociation/association of human prostatic acid phosphatase.

Authors:  Ewa Luchter-Wasylewska; Marcin Wasylewski; Klaus-Heinrich Röhm
Journal:  J Protein Chem       Date:  2003-04

2.  Prostatic acid phosphatase is an ectonucleotidase and suppresses pain by generating adenosine.

Authors:  Mark J Zylka; Nathaniel A Sowa; Bonnie Taylor-Blake; Margaret A Twomey; Annakaisa Herrala; Vootele Voikar; Pirkko Vihko
Journal:  Neuron       Date:  2008-10-09       Impact factor: 17.173

3.  High-throughput screen identifies cyclic nucleotide analogs that inhibit prostatic acid phosphatase.

Authors:  Eric S McCoy; Wendy A Lea; Bryan T Mott; David J Maloney; Ajit Jadhav; Anton Simeonov; Mark J Zylka
Journal:  J Biomol Screen       Date:  2012-11-27

4.  Decreased Equilibrative Nucleoside Transporter 1 (ENT1) Activity Contributes to the High Extracellular Adenosine Levels in Mesenchymal Glioblastoma Stem-Like Cells.

Authors:  Sebastián Alarcón; María de Los Ángeles Toro; Carolina Villarreal; Rómulo Melo; Rodrigo Fernández; Angel Ayuso Sacido; Daniel Uribe; Rody San Martín; Claudia Quezada
Journal:  Cells       Date:  2020-08-18       Impact factor: 6.600

5.  Recombinant mouse PAP has pH-dependent ectonucleotidase activity and acts through A(1)-adenosine receptors to mediate antinociception.

Authors:  Nathaniel A Sowa; Kunjumon I Vadakkan; Mark J Zylka
Journal:  PLoS One       Date:  2009-01-22       Impact factor: 3.240

6.  Transmembrane prostatic acid phosphatase (TMPAP) interacts with snapin and deficient mice develop prostate adenocarcinoma.

Authors:  Ileana B Quintero; Annakaisa M Herrala; César L Araujo; Anitta E Pulkka; Sampsa Hautaniemi; Kristian Ovaska; Evgeny Pryazhnikov; Evgeny Kulesskiy; Maija K Ruuth; Ylermi Soini; Raija T Sormunen; Leonard Khirug; Pirkko T Vihko
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.